Letter to the Editor: “International multi‐stakeholder consensus statement on post‐publication integrity issues in randomized clinical trials by Cairo Consensus Group”

Key Points

• The statement emphasizes key integrity issues impacting randomized clinical trials, enhancing accountability.
• Key evidence supports a shared understanding among stakeholders, strengthening credibility in research.
• Consensus among an international group outlines best practices for ethics and data integrity in trials.
• Highlights the need for ongoing dialogue to address integrity challenges and improve future studies.